
Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS): Regulatory Insights and Industry Case Study
About this event
This webinar focuses on the established role of GMP-compliant Next Generation Sequencing (NGS) in quality control for cell and gene therapies. With evolving regulatory guidelines addressing advanced therapeutic products, NGS offers a robust and highly sensitive approach to ensure compliance and product safety.
Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS): Regulatory Insights and Industry Case Study is a webinar from BioPharma Webinars focused on Data. The event is scheduled for Monday, February 3, 2025. UPCOMING provides an independent event listing and directs attendees to BioPharma Webinars's website to complete registration or viewing.
Topics covered
Frequently asked questions
Who is hosting Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS): Regulatory Insights and Industry Case Study?
Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS): Regulatory Insights and Industry Case Study is hosted by BioPharma Webinars.
When is Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS): Regulatory Insights and Industry Case Study?
Advancing Biomanufacturing Quality Control with GMP Next Generation Sequencing (NGS): Regulatory Insights and Industry Case Study is scheduled for Monday, February 3, 2025.
Where does registration take place?
Registration or viewing is completed on BioPharma Webinars's website.
What format is this event?
This is an online webinar.
Which topics does this event cover?
The event covers Data.



